Rchr
J-GLOBAL ID：201501012968346010   Update date: Nov. 20, 2024

MASAYA SUGIYAMA

MASAYA SUGIYAMA
Research theme for competitive and other funds  (10)：
  • 2020 - 2023 Research for analysis of receptor gene used by hepatitis B virus
  • 2017 - 2020 Research on effect of macrophage on liver fibrosis in a mouse model of hepatitis B
  • 2016 - 2019 Comprehensive understanding for the relationship between HLA class II genes and chronic hepatitis B infection
  • 2015 - 2018 Survey on the measures against viral hepatitis in developing countries of Asia and Africa
  • 2013 - 2016 Molecular basis of liver fibrosis progression in humanized mouse model infected with HBV
Show all
Papers (205)：
  • Shinichiro Morioka, Mio Nikaido, Shinya Tsuzuki, Satoshi Kutsuna, Sho Saito, Kayoko Hayakawa, Masaya Sugiyama, Norio Ohmagari. Retraction notice to < Epidemiology of post-COVID conditions beyond 3 years and factors associated with their persistence longer than 2 years: A cross-sectional study> <[Journal of Infection and Chemotherapy 30 (2024) 734-740]>. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024
  • Naohiro Yasuura, Goki Suda, Masatsugu Ohara, Akimitsu Meno, Takuya Sho, Risako Kohya, Takashi Sasaki, Tomoka Yoda, Sonoe Yoshida, Qingjie Fu, et al. Positivity of high-sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non-HBV-related HCC. Alimentary pharmacology & therapeutics. 2024
  • Haruki Uojima, Kazumi Yamasaki, Masaya Sugiyama, Masayoshi Kage, Norihiro Ishii, Ken Shirabe, Hisashi Hidaka, Chika Kusano, Miyako Murakawa, Yasuhiro Asahina, et al. Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation. Journal of Gastroenterology. 2024
  • Kei Miyakawa, Masakazu Machida, Tomoyuki Kawasaki, Masatoshi Kakizaki, Yayoi Kimura, Masaya Sugiyama, Hideki Hasegawa, Akihiro Umezawa, Hidenori Akutsu, Akihide Ryo. Replication efficiency of SARS-CoV-2 Omicron subvariants BA.2.75, BA.5, and XBB.1 in human mini-gut organoids. Cellular and molecular gastroenterology and hepatology. 2024
  • Shinichiro Morioka, Mio Nikaido, Shinya Tsuzuki, Satoshi Kutsuna, Sho Saito, Kayoko Hayakawa, Masaya Sugiyama, Norio Ohmagari. Epidemiology of post-COVID conditions beyond 3 years and factors associated with their persistence longer than 2 years: A cross-sectional study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2024
ｍore...
MISC (236)：
  • 青柳東代, 飯島尋子, 若江亨祥, 渡士幸一, 鈴木亮介, 政木隆博, 政木隆博, 杉山真也, 坪田昭人, 島田紀朋, et al. C型肝炎ウイルス除去後の病態,発癌のメカニズム. 肝細胞研究会プログラム・抄録集. 2023. 30th
  • 伊達朋子, 渡邉則幸, 杉山真也, 溝上雅史, 鈴木亮介, 相崎英樹, 村松正道, 脇田隆字, 脇田隆字. Establishment of infectious genotype 5 HCVcc. 日本ウイルス学会学術集会プログラム・予稿集(Web). 2023. 70th
  • 青柳東代, 飯島尋子, 松田麻未, 若江亨祥, 渡士幸一, 鈴木亮介, 政木隆博, 杉山真也, 坪田昭人, 島田紀朋, et al. Correlation between hepatocellular organelles, gene expression abnormalities and carcinogenesis following elimination of hepatitis C virus. 日本ウイルス学会学術集会プログラム・予稿集(Web). 2023. 70th
  • 相崎英樹, 青柳東代, 飯島尋子, 松田麻未, 若江亨祥, 渡士幸一, 鈴木亮介, 政木隆博, 政木隆博, 杉山真也, et al. C型肝炎ウイルス除去後の病態,発癌のメカニズム. 臨床化学(Web). 2023. 52
  • 永田尚義, 竹内直志, 増岡弘晃, 青木亮, 石金正裕, 杉山真也, 須田亙, 中西裕美子, 木村基, 秋山徹, et al. The uniqueness of human cytokine dynamics associated with gut microbiota and its metabolites in COVID-19 and its complications. 月刊臨床免疫・アレルギー科. 2023. 80. 2
ｍore...
Patents (1)：
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM